ArtVentive Medical Group, Inc. (OTC Bulletin Board: AVTD) announced today excellent clinical results in conjunction with expanded enrollment in the ArtVentive Endoluminal Occlusion System, or ArtVentive EOS(TM) device, OCCLUDE I post-market surveillance study.
http://bit.ly/1lgd4cY
No comments:
Post a Comment